Yayınlar & Eserler

Yayın Ağı
Makaleler 8
Tümü (8)
SCI-E, SSCI, AHCI (8)
SCI-E, SSCI, AHCI, ESCI (8)
Scopus (8)
TRDizin (1)

1. Spitz Nevus with HRAS Q61R Arising in a Giant Nevus Spilus of the Leg

UZUNÇAKMAK T. K., Zahedi N., Onenerk A. M., AYDIN ÜLGEN Ö.
Dermatology Practical and Conceptual , cilt.16, sa.3, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. In vitro and in vivo assessment of orange waste-derived flavonoid-incorporated poly(ε-caprolactone)/gelatin nanofiber dressings for wound healing

Aktürk Sertbaş A., Dikmetaş D. N., Devecioğlu D., Demiröz Uslu A., Yavuz E., Sirkeci C. B., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.113, 2025 (SCI-Expanded, Scopus)

3. Cd30-low transformed mycosis fungoides with th2 polarization and high proliferative index: partial response to brentuximab vedotin

ZAHEDI N., Kilgin H., KAYMAZ S., Demiro A. S., AYDIN ÜLGEN Ö., ENGİN B.
EUROPEAN JOURNAL OF CANCER , cilt.229, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. CR-1 expression of cutaneous melanoma tumour cells and correlation with histopathologic and prognostic parameters

ÖNENERK MEN A. M., Namal A. H., AYDIN ÜLGEN Ö., TURNA Z. H.
VIRCHOWS ARCHIV , cilt.487, 2025 (SCI-Expanded, Scopus)

5. Melanocytic tumors with spitzoid morphology: correlation of clinicopathologic features and FISH analysis

Ünlüer Kapışkay D., AYDIN Ö., ince u., Demirkesen C.
Turkish Journal of Medical Sciences , cilt.53, sa.4, ss.924-933, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

6. Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey

Erdogan M., Aydin O., SEYAHİ E.
RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.4, ss.717-723, 2022 (SCI-Expanded, Scopus)

7. Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma

Yulek O., BATUR Ş., Ozcan K., Yol C., AYDIN ÜLGEN Ö.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , cilt.22, sa.6, ss.894-900, 2022 (SCI-Expanded, Scopus) Creative Commons License

8. Phylogeny and evolution of infectious bursal disease virus circulating in Turkish broiler flocks

Yilmaz A., Turan N., Bayraktar E., Gurel A., Cizmecigil U. Y., Aydin O., et al.
POULTRY SCIENCE , sa.5, ss.1976-1984, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. Proliferating Pilar Tumors: Could Immunohistochemistry be Helpful to Differ Benign and Malignant Forms?

YILDIZ P., AYDIN ÜLGEN Ö., Yol C., DEMİRKESEN C.
109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los-Angeles, Şili, 29 Şubat - 05 Mart 2020, cilt.33, ss.511-512, (Özet Bildiri)

2. Sigara Dumanının Sıçanlarda Yağ Dokusu Grefti Sağkalımına Etkisinin Deneysel Olarak Araştırılması

ŞAHİN A., AYDIN Ö., KONUKOĞLU D., ÇETİNKALE O.
TÜRK PLASTİK VE REKONSTRÜKTİF VE ESTETİK CERRAHİ DERNEĞİ 39.ULUSAL KURULTAYI, Antalya, Türkiye, 11 - 14 Ekim 2017, ss.16, (Özet Bildiri)

3. Concomitant endometriosis in malignant and borderline ovarian tumours

Oral E., Ilvan S., Aydin O., Yilmaz H., Kumbak B., Bese T., et al.
31st Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE), Lisbon, Portekiz, 14 - 17 Haziran 2015, cilt.30, ss.271-272, (Özet Bildiri)

4. ER/PR/HER2 receptor discordance between primary tumors and corresponding axillary metastases in curatively resected node positive breast cancer patients

Ozturk M., Turna H., Aydin O., Tural D., Demirelli F., Ozguroglu M., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Gastrointestinal Stromal Tumor Metastatic to Bone: Clinicopathological and Molecular Features of 29 Cases, Including 8 Previously Unreported Cases

Kosemehmetoglu K., Kaygusuz G., Fritchie K., Aydin O., Yapicier O., Coskun O., et al.
102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Maryland, Amerika Birleşik Devletleri, 2 - 08 Mart 2013, cilt.26, (Özet Bildiri)

6. National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey

Dursun A., Bavbek S., Misirligil Z., Erdener F., Buyukozturk S., Aydin O., et al.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.675-676, (Özet Bildiri)

7. The Importance of NF Kappa-B and COX-2 Expressions in Pancreatic Adenocarcinomas

Erdamar S., Aydin O., Dirican A., Dogusoy G., Goksel S.
98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Massachusetts, Amerika Birleşik Devletleri, 7 - 13 Mart 2009, cilt.22, (Özet Bildiri)

8. The importance of COX-2 expression in pancreatic ductal adenocarcinomas

Aydin O., Erdamar S., Karakas N., Yasayan G., Ozucer B., Yamac P., et al.
27th International Congress of the International-Academy-of-Pathology, Athens, Yunanistan, 12 - 17 Ekim 2008, cilt.53, ss.124, (Özet Bildiri)

9. Expression of C-KIT, HER-2 tyrosine kinase receptors and cell adhesion molecules (E-cadherin and catenin) in colorectal carcinomas and their relationship with poor prognosis

Erdamar S., Dogusoy G., Aydin O., Tekeoglu S., Sohtaoglu M., Gocener S., et al.
92nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, Kiribati, 22 - 28 Mart 2003, cilt.16, (Özet Bildiri)

10. Antimicrobial resistance patterns of the pathogenic bacteria isolated from stool cultures of patients with acute diarrhea in Istanbul, Turkey

Ozturk R., Basaran G., Engin A., Akbal H., Vural S., Palaz F., et al.
10th Mediterranean Congress of Chemotherapy, Antalya, Türkiye, 20 - 25 Ekim 1996, ss.341-344, (Tam Metin Bildiri) Sürdürülebilir Kalkınma
Metrikler

Yayın

69

Yayın (WoS)

62

Yayın (Scopus)

54

Atıf (WoS)

437

H-İndeks (WoS)

13

Atıf (Scopus)

498

H-İndeks (Scopus)

14

Atıf (Scholar)

70

H-İndeks (Scholar)

5

Atıf (Sobiad)

1

H-İndeks (Sobiad)

1

Proje

3

Tez Danışmanlığı

2

Açık Erişim

8
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 9: AMAÇ 9: SANAYİ, YENİLİKÇİLİK VE ALTYAPI
SDG 16: AMAÇ 16: BARIŞ VE ADALET